TNYA Tenaya Therapeutics Inc
Company Analysis
Latest News
🟢 Tenaya Therapeutics is trading 11% up today as biotech stocks gain
Tenaya Therapeutics is trading at $0.42 (+10.78%), with biotech-sector strength the strongest available explanation; no company-specific catalyst was...
🟢 Tenaya Therapeutics is trading 5% up today amid a biotech-sector rally
Tenaya Therapeutics is trading at $0.40, up +5.03%, alongside a biotech-sector rally; this offers a sector-level explanation, not a confirmed company...
🔴 Tenaya Therapeutics falls 5.4% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🟢 Tenaya Therapeutics is trading 5% up with no confirmed company-specific catalyst
Tenaya Therapeutics is trading 5.02% up at $0.42, with no confirmed company-specific announcement or catalyst identified for the gain. - The reported price...
🟢 Tenaya Therapeutics is trading 7.1% up in pre-market with no confirmed catalyst
Tenaya Therapeutics is trading 7.14% higher at $0.42 in pre-market on October 15, 2026; no confirmed company-specific catalyst for the rise was identified. -...
🟢 Tenaya Therapeutics is trading 8.58% up in after-hours trading with no confirmed company-specific catalyst
Tenaya Therapeutics is trading at $0.42, up 8.58% in after-hours trading, with no confirmed company-specific catalyst identified. - A preliminary proxy filing...
🔴 Tenaya Therapeutics is trading 15.5% down — no confirmed catalyst identified
Tenaya Therapeutics is trading 15.5% down at $0.42, and no confirmed company-specific catalyst for the October 14 move was identified. - An October 14 Form PRE...
🔴 Tenaya Therapeutics is trading 5% down with no confirmed company-specific catalyst
Tenaya Therapeutics is trading 5.02% down at $0.54 on October 13, 2026, with no verified company-specific announcement or event explaining the decline. -...
🔴 Tenaya Therapeutics is trading 5% down today — no verified catalyst identified
On October 12, 2026, Tenaya Therapeutics is trading 5.17% lower at $0.55; no verified company-specific catalyst explaining the decline has been identified. -...
🟢 Tenaya Therapeutics rises 5.1% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Tenaya Therapeutics is trading 5% down with no confirmed catalyst
Tenaya Therapeutics is trading 5.14% lower now at $0.57; the cause of the October 1, 2026 decline remains unconfirmed. - No company-specific announcement or...
🟢 Tenaya Therapeutics is trading 5% up today with no confirmed catalyst
Tenaya Therapeutics is trading 5.13% higher at $0.62 now, with no company-specific reason identified for the session’s move. - No company-specific...
🟢 Tenaya Therapeutics is trading 9.59% up in pre-market on September 30, 2026; catalyst remains unclear
Tenaya Therapeutics is trading at $0.65, up 9.59%, in pre-market on September 30, 2026; the catalyst remains unclear. - No company-specific announcement dated...
🔴 Tenaya Therapeutics is trading 5% down today amid Iran-related inflation concerns
Tenaya Therapeutics is trading 5.36% down at $0.58 amid broader market pressure; no clear company-specific announcement explaining the September 28 decline...
🔴 Tenaya Therapeutics is trading 5% down today as Treasury yields reached post-2007 highs
Tenaya Therapeutics is trading at $0.63, down 5.29% on September 24, 2026, with the decline appearing tied primarily to biotech-sector weakness and broader...
🟢 Tenaya Therapeutics is trading 5% up today amid broader biotechnology strength
Tenaya Therapeutics is trading 5.16% up now at $0.71, outperforming the prior close of $0.67 amid broader biotechnology strength. - XBI was up 2.55% during...
🟢 Tenaya Therapeutics is trading 10.68% up in pre-market — no clear company-specific catalyst identified
Tenaya Therapeutics is trading 10.68% up in pre-market at $0.76, up from the September 1, 2026 close of $0.69; no clear catalyst identified. - No...
🟢 Tenaya Therapeutics is trading 7.58% up in pre-market after Nvidia’s earnings beat strengthened risk appetite
Tenaya Therapeutics is trading 7.58% up now at $0.75 amid broader risk-on sentiment; no new company-specific announcement was identified for August 27,...
🔴 Tenaya Therapeutics is trading 5.4% down today — No clear company-specific catalyst reported
Tenaya Therapeutics is trading 5.4% down at $0.66 versus its August 21, 2026 close of $0.70, with no clear company-specific catalyst identified. - No clearly...
🔴 Tenaya Therapeutics is trading 6.4% down today
Tenaya Therapeutics is trading 6.4% down now at $0.68, with no fresh company-specific announcement found to explain the decline. - Shares fell from the August...